Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist
Public ClinicalTrials.gov record NCT01197755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
(OSKIRA-3): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With Inadequate Response to a TNF-alpha Antagonist
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the effectiveness of two dosing regimens of fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking methotrexate and have had an inadequate response to a single TNF-alpha antagonist. The study will last for approximately six months.
Study identification
- NCT ID
- NCT01197755
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- Feb 2013 (Actual)
- Last update posted
- Apr 7, 2014
2010 – 2013
United States locations
- U.S. sites
- 67
- U.S. states
- 28
- U.S. cities
- 67
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | — | — |
| Research Site | Huntsville | Alabama | — | — |
| Research Site | Tuscaloosa | Alabama | — | — |
| Research Site | Mesa | Arizona | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Hot Springs | Arkansas | — | — |
| Research Site | Glendale | California | — | — |
| Research Site | La Jolla | California | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Palo Alto | California | — | — |
| Research Site | Santa Maria | California | — | — |
| Research Site | Torrance | California | — | — |
| Research Site | Tustin | California | — | — |
| Research Site | Upland | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Bridgeport | Connecticut | — | — |
| Research Site | Trumbull | Connecticut | — | — |
| Research Site | Lewes | Delaware | — | — |
| Research Site | Brandon | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Venice | Florida | — | — |
| Research Site | Zephyrhills | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Canton | Georgia | — | — |
| Research Site | Idaho Falls | Idaho | — | — |
| Research Site | Decatur | Illinois | — | — |
| Research Site | Cedar Rapids | Iowa | — | — |
| Research Site | Bowling Green | Kentucky | — | — |
| Research Site | Elizabethtown | Kentucky | — | — |
| Research Site | Crofton | Maryland | — | — |
| Research Site | Fall River | Massachusetts | — | — |
| Research Site | Worcester | Massachusetts | — | — |
| Research Site | Lansing | Michigan | — | — |
| Research Site | Flowood | Mississippi | — | — |
| Research Site | Florissant | Missouri | — | — |
| Research Site | Richmond Heights | Missouri | — | — |
| Research Site | Las Cruces | New Mexico | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Olean | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Roslyn | New York | — | — |
| Research Site | Smithtown | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Greensboro | North Carolina | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Mayfield Village | Ohio | — | — |
| Research Site | Lake Oswego | Oregon | — | — |
| Research Site | Duncansville | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | West Reading | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Hixson | Tennessee | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Amarillo | Texas | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01197755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01197755 live on ClinicalTrials.gov.